glp 1 in mounjaro GLP-1 weight loss, side effects linked to genetic variations Which GLP-1 Is Best for

h - p , Glucose-stimulated insulin secretion

These drugs are FDA-approved for type 2 diabetes and obesity, but growing evidence supports their use for rheumatoid arthritis, psoriatic arthritis, lupus, osteoarthritis, and metabolic/autoimmune diseases. Who should not take GLP-1 medications

Sitagliptin added to ongoing metformin therapy provides sustained glycemic control over 54 weeks, with a low incidence of hypoglycemia and with weight loss (Abstract 0523-P)

Emerging scientific data show a wider biologic effect of incretins in multiple organs including the liver, heart and brain, suggesting they may have a broader role in the body beyond glucose modulation

Unlike Mounjaro which activates two receptors (GLP-1 and GIP), retatrutide activates three - GLP-1, GIP and glucagon -producing the strongest weight loss results seen in any pharmacological trial to date